United Therapeutics (UTHR) Tops Q3 EPS by 82c, Beats on Revenues
Tweet
Share
E-mailGet Alerts UTHR Hot Sheet
Price: $497.97 --0%
EPS Growth %: -10.1%
Financial Fact:
Basic (in shares): 43.2M
Today's EPS Names:
SUNB, CULP, KFY, More
EPS Growth %: -10.1%
Financial Fact:
Basic (in shares): 43.2M
Today's EPS Names:
SUNB, CULP, KFY, More
Join SI Premium – FREE
United Therapeutics (NASDAQ: UTHR) reported Q3 EPS of $4.69, $0.82 better than the analyst estimate of $3.87. Revenue for the quarter came in at $446 million versus the consensus estimate of $426.43 million.
For earnings history and earnings-related data on United Therapeutics (UTHR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Casey's General Stores (CASY) Tops Q1 EPS by 69c
- Texas Capital Securities Starts Red Rock Resorts (RRR) at Buy
- Activist investor presses Xerox to review financial services arm - Bloomberg
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
